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Abstract
Realistic description of patient-specific mechanical properties of clot-
ting dynamics presents a major challenge. Available patient-specific data
falls short of robustly characterizing myriads of complex dynamic inter-
actions that happen during clotting. We propose a simplified switching
model for a key part of the coagulation cascade that describes dynamics
of just four variables. The model correctly predicts prolonged activity of
thrombin, an important enzyme in the clotting process, in certain plasma
factor compositions. The activity sustains beyond the time which is con-
ventionally considered to be the end of clotting. This observation along
with the simplified model is hypothesized as a necessary step towards effec-
tively studying patient-specific properties of clotting dynamics in realistic
geometries.
1 Introduction
Patient-specific geometry modeling, simulations with more realistic boundary
conditions, multiscale models that combine molecular mechanisms with clinical
manifestation are some of the open problems discussed in vascular biomechanics
[1]. Blood constituents vary drastically in patients and their composition plays
a significant role in determining the mechanical properties of the resulting clot
[2, 3, 4].
Current methods model generation and depletion of various constituents in
blood flow using convection reaction diffusion equations [5],
∂[Yi]
∂t
+ div([Yi]v) = div(Digrad[Yi]) +Gi, i = 1, ..., N, (1)
where [Yi] is a constituent, v is velocity, Di are diffusion coefficients, and Gi are
source terms due to clotting reaction dynamics. Number of constituents N is in
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the order of thousands; typical models consider between 30 to 40 constituents
[6, 5]; and clotting reaction models considering hundreds of constituents have
been proposed [7, 8].
1.1 Need for Simple Models
Models accounting for myriads of chemical reactions are considered as a first step
towards understanding the complex phenomena of clotting [5]. Further modeling
many such constituents are useful in a diagnostic setting where often diseases are
reflected as abnormalities in the coagulation cascade [9]. In particular reaction
dynamics alone, for example, dynamics of thrombin [10, 11], is known to be
associated with many diseases such as acute coronary syndrome [12], acute
cerebrovascular disease [13], rheumatoid arthritis [14], etc. Recent studies in
this direction include use of machine learning tools to characterize and use such
abnormalities for disease classification tasks such as identifying patients prone
to heart attacks [15, 16].
However, simplified models for the coagulation cascade are required so that:
1. the model predictions are more readily verifiable using experiments
2. augmenting chemical reaction dynamics in other phenomena such as flow
and mechanical characterization of clots in patient-specific terms become
feasible and readily comprehensible.
1.2 Challenges in Modeling the Coagulation Cascade
The chemical reaction kinetics particularly poses many challenges. Models de-
scribing kinetics using M reactions are of the form,
d[Yi]
dt
= Gi =
M∑
j=1
Sijrj([Y];kj),
s.t. [Yi](0) = [Y
0
i ],
S[Y] = S[Y0],
[Yi] ≥ 0, (2)
where Sij are stoichiometric coefficients (i = 1, ..., N, j = 1, ...,M), rj are re-
action rates, kj are parameters of the reaction rates, and [Y
0
i ] are the initial
plasma composition.
Concentration of proteins involved in coagulation and rates of reactions vary
by orders of magnitude (see Figure 1). Essentially, picomoles of trigger results
in the formation of hundreds of nanomoles of certain enzymes. This in turn
results in macroscopic formation of clots. Typically stochastic methods [17] are
used to properly account for low concentrations of species [18, 19].
The nonlinear chemical kinetics is modeled using reaction rates that typi-
cally has quadratic terms or Hill-like terms [20] . The models are very stiff and
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Figure 1: Concentration of different species during clotting in the extrinsic
pathway. The concentration of various species varies by orders of magnitude.
This poses stiffness issues in numerical schemes demanding small time steps and
excessive conditioning.
solution trajectories are unstable in many directions [21]. The rates involve neg-
ative feedback loop or cycles in the reaction cascade [22]. This poses challenges
in numerically coupling chemical reactions with flow simulations.
Moreover, there is uncertainty in the parameters of the reaction kinetics
models. It is hard to measure most of these protein factors. Many rate parame-
ters are inferred indirectly rather than being directly measured. Models used to
simulate clot in small two dimensional regions (∼100 µm) consider the dynamics
of many reactants [23]. These are inappropriate for simulations in realistic 3
dimensional flow conditions in arteries, say, in order to study atheroscelerosis or
thrombosis [23]. Reduced dimensional simplified chemical kinetics models will
help to advance the quality of patient specific simulations in realistic geometries.
1.3 Relevant Literature on Reduced Order Models
Papadopoulos et al. [23] suggested a phenomenological model for thrombin
dynamics. Based on the mechanism of thrombin dynamics, they propose a sim-
plified thrombin dynamics model using four reactions. The reactions include
dynamics of thrombin, prothrombin, platelets, and activated platelets. Using
the assumption of fast platelet activation, they derive analytical expression for
thrombin generation. These are similar to thrombin generation functions pre-
scribed by Hemker et al. [24]. The model essentially fits patient specific throm-
bin generation profiles and the effect of the plasma factor composition and
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inhibitors on the dynamics of thrombin were not emphasized.
This motivated Sagar et al. [25] to come up with a dynamical model for
thrombin generation using a hybrid strategy. The strategy combines differential
equations and several logical rules to model thrombin dynamics. They design
their approach to model systems where mechanistic insights are poor and ex-
perimental interrogation is difficult. This results in reduced order model that
has rates of the product of Hill-like terms and transfer functions that act as the
logical rules, i.e.,
ri =
kix
ηi
i
1 + kix
ηi
i
min
(
kjx
ηj
j
1 + kjx
ηj
j
,
kmx
ηm
m
1 + kmx
ηm
m
)
(3)
where r is the reaction rate, k and η are parameters, and x pertains to pro-
tein concentration or activity. Though the model shows good performance for
thrombin dynamics, the transparency in the mechanistic models such as [24]
and [23] is lost, i.e., the functionality of the model parameters and effect of
their changes is not evident. We seek a middle ground between the two simpli-
fied models where we find a dynamical model that makes use of the mechanistic
knowledge of blood coagulation and is able to account for changes in plasma
factor composition.
1.4 Proposed Model Properties
We suggest a simple phenomenological model for thrombin dynamics based on
chemical kinetics:
1. We model the stoichiometry and dynamics of certain important and easily
measurable chemical species. The model is based on the classically viewed
initiation, propagation, and termination of thrombin dynamics. Hence the
chemistry involved in the simulations offer physiological insight.
2. We model the initiation phase and the propagation/termination phase
of thrombin dynamics separately using a switching criteria for the rate
parameters. The switch separates the slow initiation phase from the latter
which is orders of magnitude faster.
3. The model we propose shows varied responses. The functionality of the
parameters are evident and different aspects of thrombin dynamics are
easily alterable.
4. A good model should be able to capture the necessary rich behavior of the
phenomena as well as generalize well in order to predict important qualita-
tive and quantitative responses. The model accounts for the physiological
effect of antithrombin and is able to predict certain important changes
in thrombin dynamics due to changes in prothrombin and antithrombin
concentration.
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5. The model is dynamical in the sense that rates for the model species could
be calculated given the current values of the model variables. In other
words, we essentially model Gi for the important species in equation 1 so
that the model could be extended to account for transport.
The simplified model proposed here is expected to make patient-specific
mechanical characterization of clots in realistic geometries feasible.
Figure 2: A schematic of the extrinsic pathway. We propose a simplified model
for thrombin dynamics. We note that events that occur after thrombin genera-
tion result in changes of mechanical properties.
2 Thrombin Generation in the Extrinsic Path-
way
2.1 Full Model
Figure 2 shows a schematic of the key elements of the extrinsic pathway involved
during clotting. We consider the extrinsic pathway because hemostasis occurs
due to tissue factor initiation. Further, we simply simplify thrombin dynamics.
Given that flow properties affect and are affected by fibrin formation, such a
simple thrombin dynamics model factors out the two phenomena. Reactions in
the intrinsic pathway could be readily accounted for due to the phenomenological
aspect of initiation in the proposed model. For simulations of the full model,
we use the extrinsic pathway developed by Hockin et al. [6]. A schematic of the
model used is shown in Figure 3.
2.2 Key Ideas Used for Simplification
We exploit the following ideas for model simplification:
5
Figure 3: A schematic of the extrinsic pathway model for thrombin dynamics
used in this work. There are essentially three elements in this network, namely,
i) thrombin initiation; ii) thrombin propagation; and iii) thrombin inhibition.
Dynamical Parametrization: Patient specificity in blood coagulation is
usually modeled using variations in the initial conditions for the differential
equations. This leads to a high-dimensional state space and specification of
dynamics in that space of many constituents as described earlier. However,
we simplify the state of the system using just four important species and then
model the dynamics of those four constituents. The effect of other constituents
are parametrized in the rates describing the dynamics of the former, i.e., the
effect of patient specificity of thrombin dynamics is described using variations in
the rate parameters of the simplified model. We show that training the model
for a specific choice of initial condition in the original state space (physiological
mean) is able to predict qualitative responses of changes in prothrombin and
antithrombin concentration in the reduced state space.
Switching: We separate the parameters in the initiation and propagation/termination
phase of thrombin dynamics using a switching model. Such switching models
are commonly used to model complex nonlinear systems [26]. Switching models
are known to result in simplified models for even chaotic dynamics. For ex-
ample, piecewise affine models are known to model chaotic behavior of many
nonlinear systems well [27]. The proposed model switches from initiation to
propagation/termination phase based on the concentration of thrombin. Such
threshold-based responses have been used in models describing initiation [23]
and platelet activation [5] in the coagulation cascade. The hybrid (switching)
model by Makin and Narayanan [28] intends to develop a comprehensive model
rather than a simplified model.
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Figure 4: A schematic of the simplified model proposed in this study. There
is fuel prothrombin, the bursting enzyme thrombin, the inhibitor antithrombin,
and the by-product thrombin-antithrombin. KS is a rate constant that models
initiation due to injury. KP is the rate of thrombin propagation. KI is the rate
of thrombin inhibition.
2.3 Simplified Model
We use the traditional simplification of the thrombin generation cascade and de-
scribe kinetics for prothrombin, thrombin, antithrombin, and thrombin-antithrombin
using the following set of reactions:
1. Thrombin Initiation: Tissue factor activates prothrombin to form throm-
bin.
II
KS−−−−−−−−−−−−→
Initiation
IIa
2. Thrombin propagation: Given that sufficient amount of thrombin (2
nM) is activated, clotting propagates via a different set of reactions.
II
KP−−−−−−−−−−−−→
Propagation
IIa
3. Thrombin inhibition: Finally normal hemostasis requires that throm-
bin generation is controlled.
IIa + AT
KI−−−−−−−−−−−−→
Termination
IIaAT
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Table 1: Switching Condition
[IIa] < 2 nM [IIa] ≥ 2 nM
KS ks > 0 0
KI ki2 > 0 ki1 > 0
KP 0 kp > 0
Corresponding to the reactions, we define the following stoichiometric model:
d
dt
[II] = −KS −KP [II][IIa]
d
dt
[IIa] = KS +KP [II][IIa]−KI [IIa][AT]
d
dt
[AT] = −KI [IIa][AT]
d
dt
[IIa-AT] = KI [IIa][AT]. (4)
where we model initiation using the rate constant KS , propagation using the
rate constant KP , and inhibition using the rate constant KI . In order to be
stoichiometrically consistent, our [IIa] is the sum of both forms of thrombin
in the full 34 variable model (the variables used in our model are drawn in
continuos lines in the full model simulation as seen in Figure 5). [IIa-AT] in our
model is the sum of the two antithrombin complex formed due to inhibition1.
Among the four species modeled, methods to measure or infer thrombin,
ATIII, and thrombin antithrombin [29, 30, 31, 32] exist. The rates in equation
4 are such that they satisfy a stoichiometric constraint, i.e.,
[II] + [IIa] + [IIa-AT] = c1
[AT] + [IIa-AT] = c2 (5)
c1 and c2 are constants defined using the initial conditions. These dependence
relations are crucial while designing experiments to properly observe the sys-
tem. For example, calibrated automated thrombogram assay is inadequate to
make proper measurements with deficient ATIII [33] due to fluorogenic substrate
depletion. In the results section, we will discuss the possibility of sustained
thrombin activity when ATIII is deficient leading to the depletion.
We propose the switching rules in Table 1 that changes the response of the
model during initiation and propagation/termination. Essentially, thrombin
propagation occurs if [IIa] crosses a threshold. For normal clotting, rate of
propagation is expected to be orders of magnitude higher than that of rate of
initiation. We also use two different inhibition rate constant ki1 and ki2 so that
rate of inhibition could be separately tuned during the two phases.
1there are other antithrombin complexes formed in the full model but they are 3 orders of
magnitude smaller than [IIa-AT] and we neglect them.
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Figure 5: Stoichiometry of thrombin and antithrombin. Only the species drawn
with a continuous straight line are considered in the model. This ensures stoi-
chiometric consistency. [IIa] or thrombin in our model is sum of the two forms
of thrombin in the full model. Similarly, [IIa-AT] or thrombin-antithrombin
in our model the sum of the two by products of thrombin inhibition due to
antithrombin in the full model.
9
3 Results and Discussion
3.1 Estimation of Model Parameters
In the simulations of the full model, clotting was initiated with 5 pM and the
plasma factor composition was set to physiological mean values [6]. We used the
data from the full model to fit parameters for the reduced model. We note that
thrombin dynamics of the full model has been corroborated with experimental
data [6]. Particle swarm optimization [34] was used for parameter estimation
and we obtained one set of parameters for the physiological mean composition.
Figure 6: Comparison of all the species modeled in the simplified model. The
simplified model captures the reponse of the corresponding variable in the full
model very well. There is a slight mismatch in the maximum amount of throm-
bin generation. This could be improved by also choosing the clot propagation
threshold ([IIa] = 2 nM) better.
We used the sum of squared differences of the normalized concentration
profiles between the common species in the full model and the reduced model
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as the objective function,
u =
1
M
M∑
m=1
4∑
i=1
(
Creducedi (m; k)− Cfulli (m)
Cconstanti
)2
(6)
wherem denotes time points and i denotes model species. Mean concentration of
prothrombin and antithrombin were used as normalization constants Cconstanti .
Comparison of the reduced and full model simulation for the physiological mean
initial composition is shown in Figure 6.
3.2 Parameter Study of the Simplified Model
We show the effect of parameters by changing them one at a time. Clot time
depends exponentially on KS (seen in Figure 7). Rate constant ki2 also controls
the clot time Figure 8. For certain combinations of KS and ki2 it takes more
than 1200 seconds for clot initiation. Both the parameters together offer more
control over dynamics of clot initiation.
Figure 7: Controlling thrombin initiation using KS . There is an nonlinear
dependence of clot time on this parameter due to Ki2.
Figures 9 and 10 show the effect of changes in the rate constants KP and ki1
respectively. The parameters offer a wide range of thrombin generation rates.
Similar to the initiation, there are certain values of KP (for a given value of ki1)
and vice versa where thrombin generation is too low. These two parameters
together offer control over simulating a wide range of thrombin propagation.
3.3 Prediction of Variation in Prothrombin and Antithrom-
bin
Finally, we check the qualitative response of the model predictions for varia-
tions in initial prothrombin and antithrombin concentrations. As seen in Figure
11, higher values of prothrombin are able to predict more thrombin generation.
This has been observed in experiments [35]. Thrombin rates during termination
could be improved using better training data and using different reaction rates.
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Figure 8: Controlling thrombin initiation using ki2. This parameter along with
KS , allows for modeling a wide range of clot times and dynamics during initia-
tion.
Figure 9: Controlling thrombin propagation using KP . As expected, variations
in the propagation rate constant is able to capture a wide range of thrombin
generation rates.
Figure 10: Controlling thrombin termination using ki1. This parameter has
more effect on the termination phase of thrombin generation.
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Similarly, lower values of antithrombin are able to predict higher thrombin gen-
eration.
Figure 11: Prediction on prothrombin variation. Thrombin activity sustains in
plasma factor composition that has excessive prothrombin. Similar prediction
is made in Figure 12 based on variations in initial antithrombin concentration.
One of the most important predictions of this model is that thrombin termi-
nation appears to halt at non-zero values (Figure 12). Such sustained activity is
also in observed in experiments when there is too much prothrombin compared
to antithrombin [35]. Inhibitors such as activated protein C may need to mod-
eled in order to account for oscillations observed in such sustained activity. In
this model, the reaction essentially runs out of the inhibitor [AT] when initiated
with a certain plasma factor composition. In such a scenario, other phenomena
like diffusion and convection will control the extent of clotting. For example,
when there is less inflow of antithrombin concentration, as in the case of stasis,
we would expect more clotting due to the presence of excess active thrombin.
The significance of antithrombin deficiency in simulations accounting for diffu-
sion has already been reported [36]. For a given value of initial prothrombin, and
given that thrombin generation proceeds normally due to sufficient rates, the
simplified model quantifies the amount of antithrombin required for thrombin
generation to terminate.
Further, active thrombin could be propagated downstream and could po-
tentially cause clotting elsewhere. This observation and model prediction on
sustained activity of thrombin are hypothesized to play a necessary role towards
effectively studying clotting in realistic geometries.
3.4 Limitations and Improvements
The simplified model proposed here, when coupled with fluid flow and transport
models, is expected to make patient-specific mechanical characterization of clots
in realistic geometries feasible. The parameters of the model need to be altered
in order to better simulate thrombin dynamics on a wider range of plasma factor
compositions. Figure 15 shows simulations from parameters identified for acute
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Figure 12: Prediction on antithrombin variation. This is the most important
and significant prediction of the model. This has been observed in thrombin gen-
eration experiments [35]. Moreover, this phenomena could be blind to markers
like TAT (IIa-AT) that infer thrombin activity.
Figure 13: Simplified model fit for different cases. By changing the parame-
ters, the model allows for a wide range of thrombin dynamics such as in acute
coronary syndromes and hemophilia A.
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coronary syndrome population mean composition [12] and a hemophilia patient
[11] (plasma factor composition of patient C in Figure 3. (B)). The hemophilia
patient simulations suggest the form of rate functions as well as the threshold
value (2 nM [IIa]) could be modeled better.
Figure 14: Comparison of thrombin generation rates in time. The better the
data aligns with the x = y line, the better is the simplification. The effect of
time lag is better emphasized in this plot compared to Figure 6.
For the mean plasma composition, Figure 15 shows the full model thrombin
rates for the simplified model at different times during clotting plotted against
the corresponding time points of the full model. The reaction rates could be
improved to better align the simulation data with the x = y line. We also
note that the objective used for simplification in equation 6 does not explicitly
penalize deviations in rates. Figure 15 shows thrombin rates for the simplified
model at different points in the state space along a particular trajectory of
the full model plotted against the corresponding rates of the full model. The
alignment is better in this case compared to figure 15. This suggests that the
simplified model takes a slightly different path compared to the full model.
We are currently working towards modifying the dynamics and the objective
so that the rates could be better simulated. We are also currently testing the
performance of the model while accounting for the effects of diffusion.
Augmenting the simplified model with fibrin dynamics would allow patient-
and event-specific characterization of thromboelastography experiments [37, 38].
This would be useful to better characterize clotting during surgeries [39]. This
work could be further improved by coupling with simplified platelet aggrega-
tion models. To conclude, the drastically simplified model proposed here is a
novel and a fertile step and subsequent progress has potential applications such
as virtual flow-diverter treatment planning [40], predicting thrombotic risk ac-
counting for flow [41], factors like injuries in tandem [42] and stenosed arteries
[43].
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Figure 15: Comparison of thrombin generation rates along the mean physiolog-
ical trajectory of the full model. The model predictions are better compared to
those in Figure 15.
4 Conclusion
We proposed a simplified model for thrombin dynamics based on the stoichiome-
try of certain important chemical species. The model, using switching of param-
eters based on a threshold, describes dynamics of thrombin akin to jump starting
a car. The simplified model fits corresponding aspects of the full model well and
different features of thrombin dynamics are easily alterable. The model is able
to predict certain important changes in thrombin dynamics due to changes in
prothrombin and antithrombin concentration. This prediction using the sim-
plified model with the potential for clinical manifestation in hypercoagulable
diseases is hypothesized as a necessary step in patient-specific simulations of
clotting in realistic geometries.
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